Pharmafile Logo
Pharmafocus logo
Advanced Search

Cancer

Showing 15 posts of 1067 posts found.

ASCO 2014: Cancer immune therapy race heats up

May 15, 2014
2014, ASCO, AZ, BMS, Cancer, Merck, Roche, chicago

A number of major players in oncology are set to showcase rival immunotherapy data at this year’s American Society of …

News
Medimmune image

MedImmune signs Incyte oncology deal

May 15, 2014
Research and Development, Sales and Marketing AstraZeneca, Cancer, Incyte, MedImmune, oncology

MedImmune, the global biologics R&D arm of AstraZeneca, is to put one of its oncology immunotherapies into development in combination …

News
Zytiga image

NICE: no early Zytiga use

May 14, 2014
Sales and Marketing Cancer, Janssen, NHS, NICE, Zytiga, johnson, prostate

Janssen has criticised NICE’s decision not to recommend Zytiga on the NHS at an earlier stage in the prostate cancer …

News
astrazeneca_plaque

AstraZeneca begins lung cancer trial

May 9, 2014
Research and Development, Sales and Marketing AstraZeneca, Cancer, MEDI4736, NSCLC, lung cancer

AstraZeneca, currently at the centre of a £63 billion bid from US giant Pfizer, has begun a late-stage trial of …

News
cancer image

Global cancer drug spend slows

May 7, 2014
Medical Communications, Research and Development, Sales and Marketing Cancer, IMS, spending

Spending on cancer drugs worldwide is slowing, according to a new report from the IMS Institute for Healthcare Informatics. The …

News

US cancer docs warn of rising drug prices

May 7, 2014
Research and Development, Sales and Marketing ASCO, Cancer, NICE, Obama, US, United States, republicans

American cancer doctors are warning that the rising price of oncology medicines is making it unaffordable for the country’s healthcare …

News
Novartis image

FDA approves Zykadia for late-stage lung cancer

April 30, 2014
Research and Development, Sales and Marketing Cancer, FDA, Novartis, lung, zykadia

Novartis’ ‘breakthrough’ drug Zykadia has been approved by the FDA to treat lung cancer patients with a particular genetic mutation. …

News
Cancer image

Cancer Research funding to be doubled

April 30, 2014
Research and Development, Sales and Marketing CRUK, Cancer, brain, breast, funding, lung

Cancer Research UK is to increase its research funding by 50% over the next decade as part of a new strategy …

News
gsk image

Mekinist shown green light by CHMP

April 28, 2014
Sales and Marketing CHMP, Cancer, GSK, mekinist, oncology, trametinib

GlaxoSmithKline’s melanoma drug Mekinist is virtually nailed on to be given approval in the European Union following a positive opinion …

News
kadcyla image

NICE rejects Kadcyla

April 23, 2014
Sales and Marketing CDF, Cancer, Genentech, Kadcyla, NHS, NICE, Roche

NICE has delivered a severe blow to Roche by rejecting its breast cancer ‘smart bomb’ Kadcyla for NHS use in …

News
Low image

How can ‘innovation’ be defined?

April 14, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, NHS, UK, eric low, innovation, myeloma

Innovation has been and continues to be an important topic of discussion for a number of different stakeholders and disciplines …

Feature
Votrient image

‘More patients want Votrient’

April 2, 2014
Research and Development, Sales and Marketing Cancer, GSK, Pfizer, Sutent, Votrient

GlaxoSmithKline is looking at patient satisfaction as a potential marketing tool for its kidney cancer drug Votrient, setting up a …

News
cruk_selfie

Social media cancer drive raises £8 million

March 26, 2014
Medical Communications, Sales and Marketing CRUK, Cancer, funding

News

Adaptimmune wins fund payout

March 26, 2014
Research and Development, Sales and Marketing Adaptimmune, Cancer, T cell, biomedical, noble, sme

Biotech firm Adaptimmune has been awarded £2.1 million from the UK government’s Biomedical Catalyst Fund, which was set up to …

News
GSK image

GSK cancer vaccine fails again

March 20, 2014
Sales and Marketing Cancer, GSK, MAGE-A3 cancer immunotherapeutic, NSCLC, lung cancer, melanoma

GlaxoSmithKline’s MAGE-A3 cancer immunotherapeutic has delivered another late-stage blow to the firm but it still vows to continue trials.  The …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026